Role of Response-to-Diuretic in Predicting Prognosis in Discharged Heart Failure Patients After an Acute Decompensation

Ponikowski, 2016, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 Fonarow, 2005, Risk stratification for in-hospital mortality in acutely decompensated heart failure, JAMA, 293, 572, 10.1001/jama.293.5.572 Boland, 1998, Natriuretic peptides in heart failure, Congestive Heart Fail, 4, 23 McDonagh, 1998, Biochemical detection of left-ventricular systolic dysfunction, Lancet, 351, 9, 10.1016/S0140-6736(97)03034-1 Maisel, 2002, Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med, 347, 161, 10.1056/NEJMoa020233 Berger, 2002, B-type Natriuretic Peptide predicts sudden death in patients with chronic heart failure, Circulation, 105, 2392, 10.1161/01.CIR.0000016642.15031.34 Feola, 2005, Prognostic value of plasma brain natriuretic peptide, urea nitrogen and creatinine in outpatients >70 years of age with heart failure, Am J Cardiol, 96, 705, 10.1016/j.amjcard.2005.04.049 Van Kimmenade, 2006, Utility of amino-terminal Pro-Brain Natriuretic Peptide, Galectin-3 and Apelin for the evaluation of patients with acute heart failure, J Am Coll Cardiol, 48, 1217, 10.1016/j.jacc.2006.03.061 Neuberg, 2002, Prospective randomized amlodipine surgical evaluation. Diuretic resistance predicts mortality in patients with advanced heart failure, Am Heart J, 144, 31, 10.1067/mhj.2002.123144 De Bruyne, 2003, Mechanisms and management of diuretic resistance in congestive heart failure, Postgrd Med, 79, 268, 10.1136/pmj.79.931.268 Sambandam, 2014, Effective use of loop diuretics in heart failure exacerbation: a Nephrologist’s view, Am J Med Sci, 347, 139, 10.1097/MAJ.0b013e31828a2962 Cowie, 2006, Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of prospective outcomes study in heart failure (POSH), Eur Heart J, 27, 1216, 10.1093/eurheartj/ehi859 Forman, 2004, Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure, J Am Coll Cardiol, 43, 61, 10.1016/j.jacc.2003.07.031 Aronson, 2010, The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure, J card Fail, 16, 541, 10.1016/j.cardfail.2010.02.001 Givertz, 2014, Renal function trajectories and clinical outcomes in acute heart failure, Circ Heart Fail, 7, 59, 10.1161/CIRCHEARTFAILURE.113.000556 Valente, 2014, Diuretic response in acute heart failure: clinical characteristics and prognostic significance, Eur Heart J, 35, 1284, 10.1093/eurheartj/ehu065 Peacock, 2003, Rapid optimization: strategies for optimal care of decompensated congestive heart failure patients in the emergency department, Rev Cardiovasc Med, 3, S41 Feola, 2017, The role of diuretic response in prognosis prediction in discharged heart failure patient: the inclusion of diuresis, Minerva Cardioang, 65, 443 Sahn, 1978, The committee on M mode standardisation of the American Society of Echocardiography: recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements, Circulation, 58, 1072, 10.1161/01.CIR.58.6.1072 Garcia, 1998, New Doppler echocardiographic applications for the study of diastolic function, J Am Coll Cardiol, 32, 865, 10.1016/S0735-1097(98)00345-3 Christenson, 2010, Multi-center determination of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure, Clin Biochem, 43, 683, 10.1016/j.clinbiochem.2010.02.001 Testani, 2014, Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure, Circ Heart Fail, 7, 261, 10.1161/CIRCHEARTFAILURE.113.000895 Di Lenarda, 2003, Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of words. The TEMISTOCLE study, Am Heart J, 146, E12, 10.1016/S0002-8703(03)00315-6 Hernandez, 2010, Relationship between early physician follow-up and 30 d readmission among Medicare beneficiaries hospitalized for heart failure, JAMA, 303, 1716, 10.1001/jama.2010.533 Di Tano, 2015, The 30 d metric in acute heart failure revisited: data from IN-HF Outcome, an Italian nationwide cardiology registry, Eur J Heart Fail, 1710, 1032, 10.1002/ejhf.290 Henderson, 2009, The regulation of inflammation by galectin-3, Immunol Rev, 230, 160, 10.1111/j.1600-065X.2009.00794.x Meijers, 2015, Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH, Eur J Heart Fail, 17, 1271, 10.1002/ejhf.407 Feola, 2016, Role of galectin-3and plasma B-type natriuretic peptide in predicting prognosis in discharged chronic heart failure patients, Medicine, 95, 26(e4014), 10.1097/MD.0000000000004014 Mejers, 2014, Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials, Am Heart J, 167, 853, 10.1016/j.ahj.2014.02.011 1997, The effect of digoxin on mortality and morbidity in patients with heart failure, N Engl J Med, 336, 525, 10.1056/NEJM199702203360801